[
    [
        {
            "time": "",
            "original_text": "艾迪药业“左右逢源”：与原料药企比财务，与创新药企比未来",
            "features": {
                "keywords": [
                    "艾迪药业",
                    "左右逢源",
                    "原料药企",
                    "财务",
                    "创新药企",
                    "未来"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "艾迪药业“左右逢源”：与原料药企比财务，与创新药企比未来",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]